AMPH icon

Amphastar Pharmaceuticals
AMPH

Overview Fund Activity

135 hedge funds and large institutions have $458M invested in Amphastar Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 18 closing their positions.

Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
58
Reduced
39
Closed
18
Calls
$221K
Puts
–
Net Calls
+$221K
Net Calls Change
+$221K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$7.68M
2
Arrowstreet Capital
2
Arrowstreet Capital
Massachusetts
$3.08M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$9.02M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$30.1M
5
Goldman Sachs
5
Goldman Sachs
New York
$4.23M

Top Sellers

1
Invesco
1
Invesco
Georgia
$17.7M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$175K
3
Millennium Management
3
Millennium Management
New York
$420K
4
EI
4
EAM Investors
California
$0
5
BlackRock
5
BlackRock
New York
$119M
Name Market Value Shares Shares
Change 		Shares
Change %
JA
151
JOYN Advisors
Georgia
– – -137 Closed
PWMG
152
Prestige Wealth Management Group
New Jersey
– – -24 Closed
VCM
153
Versant Capital Management
Arizona
– – -22 Closed
CFGS
154
Concourse Financial Group Securities
Alabama
– – – –
3 4 5 6
7